Another important conclusion from our data is that ligands of T cell immune checkpoint receptors other than PD-1 and CTLA-4 are highly abundantly expressed by ccRCC cells and myeloid cells. This evidence concerns the gene CTLA4 and nonpapillary renal cell carcinoma.